4basebio (LON:4BB) Trading 0.5% Higher - Should You Buy?

4basebio PLC (LON:4BB - Get Free Report)'s share price traded up 0.5% during trading on Thursday . The company traded as high as GBX 1,028 ($13.80) and last traded at GBX 1,005 ($13.49). 268 shares changed hands during mid-day trading, a decline of 72% from the average session volume of 965 shares. The stock had previously closed at GBX 1,000 ($13.43).

4basebio Trading Down 2.7%

The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52. The company has a market cap of £125.23 million, a price-to-earnings ratio of -1,253.33 and a beta of 1.09. The business has a 50 day simple moving average of GBX 1,060.28 and a 200 day simple moving average of GBX 1,122.88.

4basebio (LON:4BB - Get Free Report) last posted its quarterly earnings data on Tuesday, May 27th. The company reported GBX (0.94) (($0.01)) EPS for the quarter. As a group, equities analysts forecast that 4basebio PLC will post -3.43 EPS for the current year.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.